New Way to Stimulate Your Pancreas

Prandin (repaglinide), a new type 2 oral medication manufactured by Novo Nordisk, has been approved by the FDA.

The new drug stimulates the secretion of insulin from the pancreas. It was created with a quick onset and short duration of action to be especially effective at mealtimes.

Bill Poole, president of Novo Nordisk, claims that Prandin helps “people with type 2 manage their diabetes at mealtimes. Prandin is a highly potent, fast-working agent that is absorbed rapidly after dosing and clears quickly from the bloodstream.”

Prandin is expected to be available in the United States in the spring of this year.

Leave a Reply

Your email address will not be published. Required fields are marked *

Time limit is exhausted. Please reload CAPTCHA.